Related references
Note: Only part of the references are listed.Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study
J. Eimer et al.
JOURNAL OF INTERNAL MEDICINE (2021)
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Treating COVID-19: are we missing out the window of opportunity?
Jeremiah Sundararaj Stanleyraj et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis
Muhammad Aziz et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
Shruti Gupta et al.
JAMA INTERNAL MEDICINE (2021)
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
Olivier Hermine et al.
JAMA INTERNAL MEDICINE (2021)
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Carlo Salvarani et al.
JAMA INTERNAL MEDICINE (2021)
Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia
Jonathan B. Parr
JAMA INTERNAL MEDICINE (2021)
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
Imad M. Tleyjeh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
COVID-19 and the Heart
Akbarshakh Akhmerov et al.
CIRCULATION RESEARCH (2020)
Treatment algorithm for COVID-19: a multidisciplinary point of view
Felice Galluccio et al.
CLINICAL RHEUMATOLOGY (2020)
Postmortem Examination of Patients With COVID-19
Tina Schaller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Xiaochen Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Tocilizumab for the treatment of severe coronavirus disease 2019
Rand Alattar et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
T. Klopfenstein et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series
Pavan K. Bhatraju et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Tocilizumab for severe COVID-19: a systematic review and meta-analysis
Shao-Huan Lan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients
Timothee Klopfenstein et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
Saeed K. Alzghari et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
Malgorzata Mikulska et al.
PLOS ONE (2020)
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children
Caroline Diorio et al.
BLOOD ADVANCES (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi et al.
LANCET RHEUMATOLOGY (2020)